| CTRI Number |
CTRI/2025/11/097819 [Registered on: 21/11/2025] Trial Registered Prospectively |
| Last Modified On: |
12/11/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparison of airways devices (I-gel and Endotracheal Tube) on Stomach Volume and Gut Recovery After Laparoscopic abdominal Surgery in Diabetic Patients. |
|
Scientific Title of Study
|
Effect of I-gel versus endotracheal intubation on perioperative gastric volume and postoperative gastrointestinal recovery in diabetic patients undergoing laparoscopic abdominal surgeries: a randomized comparative study. |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Shreya Saxena |
| Designation |
Junior resident |
| Affiliation |
Uttar Pradesh University of Medical Sciences |
| Address |
room 116, rani laxmi bai girls hostel, UPUMS, Saifai, Etawah, Uttar pradesh, India, 206130 UPUMS, Saifai, Etawah Etawah UTTAR PRADESH 206130 India |
| Phone |
9454285194 |
| Fax |
|
| Email |
myselfshreya20@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Usha Shukla |
| Designation |
Professor and Head |
| Affiliation |
Uttar Pradesh University of Medical Sciences |
| Address |
Department of anaesthesiology ,UPUMS
Etawah UTTAR PRADESH 206130 India |
| Phone |
9412201915 |
| Fax |
|
| Email |
ushashukla1970@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Usha Shukla |
| Designation |
Professor and Head |
| Affiliation |
Uttar Pradesh University of Medical Sciences |
| Address |
Department of anaesthesiology ,UPUMS
Etawah UTTAR PRADESH 206130 India |
| Phone |
9412201915 |
| Fax |
|
| Email |
ushashukla1970@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Uttarpradesh University of medical sciences |
| Address |
Saifai, Etawah, Uttar Pradesh, 206130 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Shreya Saxena |
Uttar Pradesh University of Medical sciences |
Department of Anaesthesiology , UPUMS , Saifai , Etawah , Uttar Pradesh Etawah UTTAR PRADESH |
9454285194
myselfshreya20@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee, Saifai, UP-206130, Uttar Pradesh University of Medical Sciences |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Endotracheal intubation |
Direct laryngoscopy will be performed with an appropriate size Macintosh blade and Endotracheal tube (ETT) will be placed. The ETT will then be connected to the anesthesia workstation with previously assigned settings. The tracheal position of the ETT will be confirmed by 5-point auscultation, chest rise, and end tidal carbon dioxide readings. |
| Comparator Agent |
I-gel |
The appropriate size of I-Gel device will be inserted.
The placement of I Gel will be confirmed by resistance to further distal movement, end tidal carbon dioxide readings, and effective chest wall movement. If satisfactory insertion is not achieved with three attempts, or there is respiratory embarrassment, the patient will be removed from the study after being intubated via direct laryngoscopy. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1.patients undergoing Laproscopic abdominal surgeries
2.Body mass index between 18.5 to 24.9 kg per m2
3.American society of Anaesthesiologists physical status class 2
4.History of Diabetes mellitus for atleast 5 years or more with controlled blood sugar levels.
|
|
| ExclusionCriteria |
| Details |
1. Patient’s refusal
2. Baseline gastric volume more than 1ml per kg on the morning of surgery
3.Diagnosed cases of gastric esophageal reflux disease
4. Anticipated difficult airway
5. Chronic treatment with opioids, steroid, immunosuppresants, chemotherapy, drugs affecting gastric motility or gastric volume
6. Neurological or psychiatric conditions affecting gastric motility
7. Pregnancy |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Comparison of change in perioperative gastric volume using USG guided antral cross sectional area measurement in both the groups. |
baseline (preoperative), just after securing airway, and at the end of surgery before extubation. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Comparison of Postoperative gastrointestinal recovery
|
Time to start clear fluids ( When patient restore atleast 2 bowel sounds per minute).
Time to start Light diet ( When patient restore normal bowel sounds i.e., more than 5 sounds per minute).
Time to First gas discharge ( flatus)
Time to Achieve first bowel movement.
All these parameters will be measured from the time of extubation. |
| Measurement of hemodynamic parameters- heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure (MAP). |
At baseline (preoperative), just after securing airway, at pneumoperitoneum, and at end of surgery before extubation. |
| Measurement of intraoperative ventilatory parameters :Leak volume, leak fraction, Peak airway pressure, Plateau pressure, EtCO2. |
Just after securing airway, at pneumoperitoneum, and at end of surgery before extubation |
Degree of gastric distension
|
On insertion of laparoscope. |
Postoperative events
|
In 24 hours after extubation |
|
|
Target Sample Size
|
Total Sample Size="70" Sample Size from India="70"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/12/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="10" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The study will begin after approval from the Institutional Ethical Committee and registration with the Clinical Trials Registry – India (CTRI). After obtaining informed consent, patients will be randomly assigned to either Group A (endotracheal intubation) or Group B (I-Gel insertion) using a computer-generated random number table and opaque sealed envelopes for allocation concealment. Preoperative assessment will include antral cross-sectional area (CSA) measurement using ultrasound. Standardized general anesthesia will be administered, and airway management will follow group allocation. Ventilation settings will be consistent across groups, and intra-abdominal pressure and Trendelenburg tilt will be maintained as per surgical needs. Data collection will include antral CSA at three time points, hemodynamic parameters, intraoperative ventilatory parameters (leak volume, leak fraction, peak and plateau airway pressures, EtCO2), and gastrointestinal recovery indicators such as time to clear fluids, light diet, flatus, and bowel movement. Gastric distension will be graded by the surgeon using a 5-point Likert scale, and postoperative complications such as nausea, vomiting, and sore throat will be recorded for 24 hours. At the end of surgery, anesthesia will be discontinued and reversal agents administered, with removal of airway devices based on adequate signs of recovery. |